COVID-19 thromboembolism incidence, risk factors, and anticoagulation practices from a Chicago metropolitan US population. Am J Hematol 2022 Jun 01;97(6):E217-E220
Date
03/19/2022Pubmed ID
35303373DOI
10.1002/ajh.26541Scopus ID
2-s2.0-85127241121 (requires institutional sign-in at Scopus site) 1 CitationAuthor List
Berg S, Kim SH, Wozniak A, Odetola O, Arain S, Aleem A, Coggan J, Dave A, Elliott E, Guerrettaz R, Dalal H, Lee R, Kodali A, Moore P, Patel S, Rajakumar P, Qin S, Delgado Ramos G, Schwartz C, Esmail F, Feltman Frank R, Murchie E, Pax L, Yun N, Zhang Y, Barton K, Hagen P, Hossain N, Larson ML, Mai H, Nand S, Phelan K, Venugopal P, Stiff P, Saraf SAuthor
Ryan D. Guerrettaz MD Instructor II in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnticoagulantsChicago
Humans
Incidence
Risk Factors
Thromboembolism
Venous Thromboembolism









